Showing results (1-10 of 393) with videos related to
Sort By:
Pageof 40
Journal of the National Cancer Institute|February 1, 1982
Phase I-phase II trial of N-phosphonacetyl-L-aspartic acid given by intravenous infusion and 5-fluorouracil given by bolus injectionC Erlichman, R C Donehower, J L Speyer, et al.Cancer Chemotherapy and Pharmacology|January 1, 1982
Evaluation of weekly escalating doses of dichloromethotrexate in patients with hepatocellular carcinoma and other solid tumorsW J Tester, R C Donehower, J L Eddy, et al.Seminars in Oncology|June 1, 1992
An overview of the clinical experience with hydroxyureaR C DonehowerStem Cells (Dayton, Ohio)|January 1, 1996
The clinical development of paclitaxel: a successful collaboration of academia, industry and the National Cancer InstituteR C DonehowerRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Metabolic conversion of methotrexate in manR C DonehowerOncology (Williston Park, N.Y.)|February 24, 2001
Role of oral chemotherapy in colorectal cancerR C DonehowerCancer Treatment Reports|November 1, 1984
Hepatic toxicity of low doses of mithramycin in hypercalcemiaL Green, R C DonehowerClinical Biochemistry|April 1, 1986
Potential applications of therapeutic drug monitoring in treatment of neoplastic disease by antineoplastic agentsC ErlichmanRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
An overview of the clinical pharmacology of N-phosphonacetyl-L-aspartate (PALA), a new antimetaboliteC ErlichmanCurrent Opinion in Oncology|December 1, 1991
Novel chemotherapeutic agents in clinical developmentC ErlichmanPageof 40